Response Biomedical Corp. Announces the Hire of Mr. Darby L. Darilek as Director of U.S. Sales to Expand Its Presence and Commitment to the U.S. Market
February 26, 2013 09:00 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 26, 2013) - Response Biomedical Corp. ("Response or the Company") (TSX:RBM)(OTCBB:RPBIF) is pleased to announce that Mr. Darby L. Darilek...
Response Biomedical Corp. Announces Execution of New Distribution Agreement with Fisher HealthCare for U.S. Distribution of its Response Infectious Disease Products
January 24, 2013 17:09 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 24, 2013) - Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBIF) (Response) announced today that it has entered into a new nonexclusive...
Response Biomedical Corp. Announces Expansion of U.S. Distribution for RAMP(R) Cardiovascular Products
January 03, 2013 09:00 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 3, 2013) - Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBIF) today announced that it has entered into a distribution agreement with...
Response Biomedical Corp. to Present at Upcoming Investor Conference
January 02, 2013 18:38 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 2, 2013) - Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBIF) today announced that Chief Executive Officer, Jeffrey L. Purvin will be...
Response Biomedical Corp. Announces Third Quarter 2012 Financial Results
November 14, 2012 16:05 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 14, 2012) - Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBIF) today reported financial results for the three and nine months ended September...
Response Biomedical Corporation Schedules Third Quarter 2012 Earnings Release and Announces Conference Call
November 07, 2012 17:41 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 7, 2012) - Response Biomedical Corporation (TSX:RBM)(OTCBB:RPBIF) will release its financial results for the period ending September 30,...
Response Biomedical Corp. Announces the CE Mark of D-dimer Assay for the EU Market
November 07, 2012 09:00 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 7, 2012) - Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBIF) announced today that the Company has received CE Mark for their D-dimer Point...
Response Biomedical Corporation Announces Acquisition of Worldwide Rights of Infectious Disease Testing Due to Termination of 3M Agreements
October 02, 2012 19:19 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 2, 2012) - Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBID) (the "Company" or "Response"), announced today it has regained the worldwide...
Response Biomedical Corp. Announces Share Consolidation
September 24, 2012 17:56 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 24, 2012) - Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBIF) (the "Company" or "Response"), announced today the completion of the...
Response Biomedical Corporation Announces Share Consolidation
August 17, 2012 01:59 ET
|
Response Biomedical Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 16, 2012) - Response Biomedical Corp. (TSX:RBM)(OTCBB:RPBIF) (the "Company" or "RBM"), announced today that, in accordance with the...